Sources familiar with the matter told Dow Jones Monday the deal is driven by Amazon’s possible entry into the pharmacy market. Previous reports projected the deal could be inked in December.
Aetna’s shares closed at $174.97 Monday following the news. This is lower than the $200 per share CVS Health reportedly offered Aetna in late October, when news of the deal surfaced.
More articles on payer issues:
CMS releases Medicare Part A, B rates: 4 things to know
UnitedHealthcare adds Samsung, Garmin wearables to its wellness program
Hartford HealthCare, Anthem reach 3-year agreement
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
